It has been reported that Pentamidine suppresses the expression of hypoxia-inducible factor 1 alpha (HIF-1a) which correlates with increased vascularity, resistance to chemotherapy and radiotherapy, and poor prognosis in DU145 prostate and MDA-MB-231 breast cancer cell lines [11]. The gene discussed is HIF1A; the disease is breast cancer.